"Management now expects it to be accretive in 2025 (vs. second year post-close previously)," Saxon said in a note. "GMED continues to integrate NVRO and expects to be largely done around mid-2026." Globus Medical stock shot up 36.1%, closing at 83.89. Shares ended the regular session above their 200-day line at an eight-month high. Globus Medical Stock Jumps On Hiked Outlook Across all segments, Globus' sales grew 6.4% organically to $769 million, topping forecasts for$735 million. Adjusted earnings came i ...